Top Abstract Purchase Related
Home
>
Node
>
Subnode

Antibodies to sn RNPs in systemic lupus erythematosus

Craft, J.

Rheumatic Diseases Clinics of North America 18(2): 311-335

1992

ISSN/ISBN: 0889-857X
PMID: 1626072
Document Number: 404719
Antibodies to the Sm and RNP antigens are diagnostic hallmarks in patients with systemic lupus erythematosus. Both antigens are located on the U1 snRNP (small nuclear ribonucleoprotein particle), a complex of a small RNA and associated proteins that carry the antigenic determinants. This particle also plays an essential role in messenger RNA processing within the cell nucleus. Newer diagnostic techniques are available for detection of anti-Sm and antiRNP antibodies (the latter are now more appropriately called anti-U1 RNP antibodies) and a great deal of information on the molecular biology of snRNPs is currently available.

Document emailed within 1 workday
Secure & encrypted payments

Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Johns, A.S.; Chamley, L.; Ockelford, P.A.; Pattison, N.S.; McKay, E.J.; Corkill, M.; Hart, H. 1994: Comparison of tests for the lupus anticoagulant and antiphospholipid antibodies in systemic lupus erythematosus Clinical and Experimental Rheumatology 12(5): 523-526
Abdel Gawad, E.R.; Mansour, A.I.; Abdel Aziz, Y.A.; Soliman, A.F.; Fawzy, R.M. 2014: Role of anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus and as a marker for lupus nephropathy Egyptian Journal of Immunology 21(1): 57-65
Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165
D'Cruz, D.P.; Mellor-Pita, S.; Joven, B.; Sanna, G.; Allanson, J.; Taylor, J.; Khamashta, M.A.; Hughes, G.R.V. 2004: Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies Journal of Rheumatology 31(2): 280-285
López-Longo, F.J.; Monteagudo, I.; González, C.M.; Moreno, A.C.; Rodríguez Mahou, M.; Grau, R.; Carreño, L. 1998: Anti-BB'-Sm antibodies, anticardiolipin antibodies, and thrombosis in systemic lupus erythematosus Journal of Rheumatology 25(9): 1743-1749
Horbach, D.A.; van Oort, E.; Donders, R.C.; Derksen, R.H.; de Groot, P.G. 1996: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies Thrombosis and Haemostasis 76(6): 916-924
Reeves, W.H. 1992: Antibodies to the p70/p80 (Ku) antigens in systemic lupus erythematosus Rheumatic Diseases Clinics of North America 18(2): 391-414
Danon, Y.L.; Garty, B.Z.; Nitzan, M. 1984: Antineuroblastoma antibodies in systemic lupus erythematosus Israel Journal of Medical Sciences 20(8): 720-721
Font, J.; Casals, F.J.; Cervera, R.; Bové, A. 1987: Anticardiolipin antibodies and thrombosis in systemic lupus erythematosus Medicina Clinica 89(1): 41
Ivanova, S.M.; Alekberova, Z.S.; Preobrazhenskiĭ, D.V.; Speranskiĭ, A.I. 1982: Antibodies to extractable nuclear antigens in systemic lupus erythematosus Terapevticheskii Arkhiv 54(6): 54-57
Aho, K.; Koskela, P.; Mäkitalo, R.; Heliövaara, M.; Palosuo, T. 1992: Antinuclear antibodies heralding the onset of systemic lupus erythematosus Journal of Rheumatology 19(9): 1377-1379
Miyoshi, Y.; Kilpatrick, K.A.; Kelley, R.O.; Searles, R.P.; Williams, R.C. 1985: Antibodies to lymphocyte membrane preparations in systemic lupus erythematosus Journal of Rheumatology 12(6): 1097-1104
Vandersteen, P.R.; Provost, T.T.; Jordon, R.E.; McDuffie, F.C. 1982: C2 deficient systemic lupus erythematosus: its association with anti-Ro (SSA) antibodies Archives of Dermatology 118(8): 584-587
Leaños Miranda, L.; Bustos López, H.H.; Fraga Mouret, A.; Blanco Favela, F.; Dalila Pascoe Lira, M.E.; Dalila Pascoe Lira, C. 1998: Antibodies against prolactin in patients with systemic lupus erythematosus and hyperprolactinemia Ginecologia y Obstetricia de Mexico 66: 179-186
Panem, S.; Check, I.J.; Henriksen, D.; Vilcek, J. 1982: Antibodies to alpha-interferon in a patient with systemic lupus erythematosus Journal of Immunology 129(1): 1-3
Levy, R.A.; Gharavi, A.E.; Sammaritano, L.R.; Habina, L.; Qamar, T.; Lockshin, M.D. 1990: Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis Journal of Rheumatology 17(8): 1036-1041
Monegat, J.N.; Joller-Jemelka, H.I.; Grob, P.J. 1974: Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases Schweizerische Medizinische Wochenschrift 104(45): 1614-1623
Fijnheer, R.; Horbach, D.A.; Donders, R.C.; Vilé, H.; von Oort, E.; Nieuwenhuis, H.K.; Gmelig-Meijling, F.H.; de Groot, P.G.; Derksen, R.H. 1996: Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus Thrombosis and Haemostasis 76(4): 514-517
Smolen, J.S.; Hassfeld, W.; Graninger, W.; Steiner, G. 1990: Antibodies to antinuclear subsets in systemic lupus erythematosus and rheumatoid arthritis Clinical and Experimental Rheumatology 8(Suppl 5): 41-44